ADC Therapeutics SA (NYSE:ADCT)

BATS BZX Real-Time Price
As of Sep 25
 -0.0085 / -1.05%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for ADC Therapeutics SA have a median target of 6.00, with a high estimate of 12.00 and a low estimate of 2.00. The median estimate represents a +650.00% increase from the last price of 0.80.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in ADC Therapeutics SA. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18.63%
Growthannually -32.77%


Growthquarterly 15.99%
Growthannually -54.84%
Key to the earnings and sales forecast charts.